23
Eng
lis
h
1.1 Possible applications
The
ARTROMOT®-F
is a motorized motion
device used for
C
ontinuous
P
assive
M
otion
(
CPM
) of the hand and finger joints.
Its use is an important contribution to
medical-therapeutic treatment both in cli-
nics/doctors’ offices and in rental services.
1.2 Objectives of therapy
CPM therapy with the
ARTROMOT®-F
mainly serves to prevent the negative
impact of immobilization, regain painless
movement of the joints quickly, and ensure
a faster healing process with a positive
functional result.
Other objectives of the therapy include:
– Prevention of joint stiffness
(arthrofibrosis)
– Better joint metabolism
– Support for the healing of cartilage
areas and damaged ligaments
– Faster haematoma resorption
– Better lymph and blood circulation
– Prevention of thrombosis and embolism
– Reduction of post-operative pain
1.3 Indications
The motion device is indicated in the
treatment of most injuries, postoperative
states, and diseases of the hand and finger
joints, for example:
– Capsulotomy, arthrolysis and tenolysis
for post-traumatic stiffness of MCP and
PIP joints
– Open reduction and rigid internal fixati-
on of intraarticular, diaphyseal
and metaphyseal fracture of the
phalanges and metacarpals
– Flexor and extensor tendon tenolysis
– Flexor and extensor tendon synovecto-
mies, following arthrotomy and draina-
ge of acute septic arthritis
– Prothetic replacement of MP and PIP
joints
– Stable fractures
– Crush injuries of hand without fractures
or dislocations
– Hand or digit reattachment
– Dupytren’s Contracture Release
– Burn injuries
– Reflex Sympathy Dystrophy (RSD)
The
ARTROMOT®-F
should
not be used
with:
– Untreated or uncontrolled infections
– Unstable fractures
– Hemorrhage
m
PRECAUTION!
NOTE:
Upon using the device, if signs of
infection such as hyperthermia, fever,
redness, irritation, warmth, swelling,
bleeding and/or increased persistent pain
are present, discontinue operation of the
device and contact the pa tient’s physician.
Do not proceed with treatment until the
physician has approved continued use of
the device.
1. How to use the motion device
MOT-301-DE_USA-GB_Rev_03-04-01-2017_DV3.indd 23
17.01.17 10:10
Summary of Contents for ARTROMOT-F
Page 2: ...MOT 301 DE_USA GB_Rev_03 04 01 2017_DV3 indd 2 17 01 17 10 10 ...
Page 5: ...5 9 10 11 12 13 14 16 15 MOT 301 DE_USA GB_Rev_03 04 01 2017_DV3 indd 5 17 01 17 10 10 ...
Page 21: ...21 MOT 301 DE_USA GB_Rev_03 04 01 2017_DV3 indd 21 17 01 17 10 10 ...
Page 37: ...37 MOT 301 DE_USA GB_Rev_03 04 01 2017_DV3 indd 37 17 01 17 10 10 ...
Page 38: ...38 Notes MOT 301 DE_USA GB_Rev_03 04 01 2017_DV3 indd 38 17 01 17 10 10 ...
Page 39: ...39 Notes MOT 301 DE_USA GB_Rev_03 04 01 2017_DV3 indd 39 17 01 17 10 10 ...
